Aim of the study:evaluate the safety and efficacy of sutureless glue free limbal conjunctival autograft for the management of primary pterygium surgery.
INTRODUCTION
Pterygium (derived from pterygion, ancient Greek for wing) is a common ocular disease seen mostly in tropical and subtropical areas. It is an abnormal overgrowth of fibrovascular tissue arising from the subconjunctiva toward the cornea, almostalways in the palpebral fissure and thought to be caused by increased light exposure, dust, dryness, heat and wind.
[1] Although it can be easily excised, it has a high rate of recurrence ranging between 24% and 89%
. [2] With the popularity of conjunctivalautograft and use of antimetabolites such as mitomycin C and 5-Fluorouracil the incidence of recurrence has been greatly reduced up to 12%.
[ [3] [4] [5] The role of carbon dioxide and excimer lasers in pterygium surgery remains uncertain. Additionally, the relative benefits and risks are debatable of physiochemical methods to prevent recurrence. For example possible complications of mitomycin C and beta-irradiation include aseptic necrosis of the sclera and cornea, cataract, persistent epithelial defects and visual loss . [6] Therefore, a simple surgical procedure that can reduce the recurrence rate to an acceptable level with minimal complications and without the use of potentially toxic drugs or radiotherapy would be ideal for the management of pterygium. Some reports favor the use of fibrin glue above sutures.
[7-8]
The use of fibrin gluehas been reported to improve comfort, decrease surgical time, reduce complications and recurrence rates.
[9-10] Suture-related complications include infection, prolonged operating time, postoperative discomfort, suture abscesses, buttonholes, and pyogenic granuloma which usually require a second surgery for removal [11] . Plasma-derived fibrin glue has the potential risk ofdisease transmission and anaphylaxis in susceptible individuals. [12, 13] Sutureless grafting has been used successfully in gingival graftsand represents a similar mucosal membrane tissue environment to the conjunctiva of the eye. [14] In this study, weevaluate the safety and efficacy of sutureless glue free 721 limbalconjunctivalautograftfor the management of primary pterygium surgery. The goals of pterygium surgery were to remove the pterygium, restore the conjunctival anatomy, leave the cornea as smooth and clear as possible, and prevent recurrence. Simple pterygium excision wasperformed under peribulbar anesthesia using 2% Lidocaine. After an eyelid speculum was inserted,local anesthesia was used to balloon the pterygium separating it from the sclera. Excision consisted of detachment of the pterygium head using a crescent knife and dissection of the body from the overlying conjunctiva in a smooth clear plane as possible using blunt and sharp dissection. Subsequently, the subconjunctival pterygium tissue and the thickened segment of conjunctiva and adjacent Tenońs capsule were excised leaving bare sclera. Then the size of bare sclera was measured with calipers and was documented in millimeters. For harvesting the conjunctivalautograft, the globe was rotated downward with a limbal traction suture. The superior temporal quadrant of bulbar conjunctiva was injected with 1 cc of 2%, Lidocaineto facilitate separation of the conjunctiva from Tenon's capsule, then a marker was used to mark the four corners of the conjunctivallimbal graft that aws created 2 mm larger in width and length than the recipient bed. A small opening was created and a careful bluntdissection with Wescott scissors was performed until the entire graft was free from Tenon's reaching the limbus to include limbal stem cells that act as a barrier to the conjunctival cells migrating onto the corneal surface. Subsequently, the edges of the graft were cut by Vannas scissors. Forceps was used to gently slide the graft to the recipient bed with the epithelial side up and keeping the limbal edge toward the limbus. Hemostasis was allowed to occur spontaneously without use of cautery to provide autologous fibrin to glue the conjunctivalautograft naturally in position without tension, and the scleral bed was viewed through the transparent conjunctiva to ensure that residual bleeding did not lift the graft. Small central hemorrhages were lampooned with direct compression. The graft was held in position for 10 min by application of gentle pressure over the graft with fine non-toothed forceps. The stabilization of the graft was tested with a Merocel spear centrally and on each free edge to ensure firm adherence to the sclera. The eye was bandaged for 48 hours. Postoperatively, a pressure eye patch was applied. Analgesia in the form of 50 mg diclofenac tablets was prescribed two times daily for 5 days. Postoperative medications included,Tobramycin and dexamethasone eye ointment, three times daily for 1 week with gradual tapering over 3 weeks and liberal use of topical lubricating eye drops (0.5% Carboxymethyl cellulose sodium)four times daily for 4 weeks. Patients were instructed to avoid rubbing their eyes for 24 hoursand avoid dust, heat, as well as direct sun exposure. Patients were also advised to wear sun glasses for 7 days. All patients were followed up after 48 hours, weekly for one month then monthly for12 months.The main postoperative outcomes included the recurrence (which was defined as fibrovascular proliferation invading the cornea more than 1.5 mm at the site of previously excised pterygium), graft dehiscence and graft retraction. The secondary outcomes included the duration of surgery, postoperative pain, foreign body eye sensation, photophobia, hyperemia, chemosis, and complications as, persistent epithelial defect, dellen, inclusion cyst, pyogenic granuloma, conjunctival edema, corneo-scleral necrosis, infective scleritis, keratitis andendophthalmitis.
PATIENTS AND METHODS

STATISTICAL ANALYSIS
Data were collected, coded, revised and entered to the Statistical Package for Social Science (IBM SPSS) version 20. The data were presented as number and percentages for the qualitative data, mean, standard deviations and ranges for the quantitative data with parametric distribution and median with inter quartile range (IQR) for the quantitative data with non parametric distribution. Spearman correlation coefficients were used to assess the significant relation between two quantitative parameters in the same group . The confidence interval was set to 95% and the margin of error accepted was set to 5%. So, the pvalue was considered significant as the following: P > 0.05: Non significant (NS) P < 0.05: Significant (S) P < 0.01: Highly significant (HS).
RESULTS
All pterygia were located nasally in all cases. Mean patient age±SD was 52.50 ± 18.31 years (Range: 30-75 years). They were 12 males(70.6%) and 5females (29.4%). Pterygia were presented in the right eye in11 cases (55%) and in the left eye in 9 cases (45%). Mean horizontal graft size±SD was 6.4±1.1mm(Range: 5-8 mm), while mean vertical graft size ± SD was 5.8±0.8mm (Range: 4-7 mm). Mean duration of graft fixation±SD was 11.5±1.82 minutes. (Range: 9-14 minutes). Mean operative time±SD was 26.3±1.41 minutes(Range: 24-28 minutes). There was good cosmetic outcome in all cases, with minimal postoperative pain and discomfort. Mean follow up period U+U SD was 9.2 U+U 1.6 months (Range: 7-12 months). No graft dislocation, dehiscence or recurrences of pterygia were reported during the follow up period (Table  1) . Conjunctival edema occurred in one eye (5%). It resolved gradually within the first post-operative week. Faint corneal nebula occurred at the site of excised pterygia in one eye (5%) andgraft retraction in 2 eyes(10%). No Conjunctival cyst ordellen were reported. There were no anesthetic complications, graft necrosis, symblepharon, scleral necrosis or thinning, excessive bleeding, globe perforation or injuryto the medial rectusmuscle (Table2).
DISCUSSION
Surgical techniques for the management of pterygium vary, but high recurrence rates after successful excision remain a challenge. The aim of pterygium surgery is to excise the pterygium and prevent its recurrence [15] .However, there are very few clinical guidelines for optimal treatment that lower recurrence and complication rates. The variety of techniques, range from the bare scleraprocedure to more complex approaches, such as amniotic membrane transplantation and lamellar keratoplasty, including conjunctivalautograft, and limbalconjunctival transplant, conjunctival flap, conjunctival rotation autograft surgery, cultivated conjunctival transplant (ex-vivo expanded conjunctival epithelial sheet) and the use of fibrin glue. Adjunctive therapies include Beta irradiation, 5-Fluorouracil,Daunorubicin, and Mitomycin C (MMC).
[ [15] [16] [17] [18] [19] Bare sclera excision (BSE) has an unacceptably high recurrence rate (40-60%) and has become obsolete. BSE with perioperative MMC [20] [21] [22] preoperative subconjunctival injection, intraoperative application and postoperative drops had yielded better outcomes, but the risk of complications has made these procedures less favorable. BSE with beta irradiationhas resulted in encouraging outcomes (13% recurrence); however it has some reported complications. Pterygium excision with limbalconjunctivalautograft, has been reported to be more effective with low recurrence rate but it may compromise the corneal stem cell population. Additionally, adjunctive use of amniotic membrane graft results in low recurrence rate but it is costly.
[24, 25] Fibrin glue has been used as an alternative to sutures for securing the conjunctival grafts.One study has reported recurrence rate of 5.3% for glue versus 13.5% for sutures and suggested that immediate adherence of the graft and lack of postoperative inflammation may inhibit fibroblast ingrowth and reduce the recurrence.The main issue in using commercial fibrin glue, despite viral inactivation techniques, is the transmission of infectious agents such as parvovirus B19 (HPV B19). Furthermore, anaphylactic reaction has been reported after the use of (TISSEEL) fibrin sealant which was due to bovine protein aprotinin.Foroutanet al.
[23] prepared autologous fibrin glue, though that it is much safer but not yet used widely because of the duration it takes to procure the fibrin and lack of laboratory facilities at all centers.
They reported that fibrinogen compounds may be susceptible to inactivation by iodine preparations used for conjunctival disinfection before pterygium surgery.
[23]
In our study we used the technique of sutureless and glue freeconjunctivallimbalautograft,in primary pterygium surgery withoutrecurrence (0%) during follow up period of one year. Massaoutiset al. [26] stated that the concept of surgical success in pterygium surgery can be defined as the provision of a white cosmetic conjunctiva, with no persistent symptoms and a low recurrence rate (less than 10%). The recurrence rate in our study agrees with the Massaoutiset al.'s criteria. The recurrence rate is also similar to Malik et al. [27] who reported recurrence rate of 2.5% using a similar procedure of sutureless and glue free graft, with a follow up period of 30 months. Graft dehiscence is a recognized complication of techniques using glue. Froutanet al.
[23] reported 13.33% rate of graft dehiscence using autologous fibrin and attributed this to a low concentration of thrombin and fibrinogen in autologous glue compared to a commercial preparation. In our study no graft dehiscence occurred.We attributed this to the strict patient instructions to use a protective shell and not to rub the eye in the firstpost-operative week, and to the meticulous dissections of thin donor limbalconjunctivalautograft free of Tenon's capsule. Graft retraction was reported by Tan [10] who advocated sub-conjunctival fibrosis and recommended meticulous dissection of subepithelial graft tissue. Foroutanet al.
[23] reported 20% graft retraction. In our study graft retraction was reported in 2 eyes out of 20 (10%).We think that all graft retraction in our study was due to conjunctivalchemosis and edema.They showed complete resolution within 24 hours using a combination of Tobramycin and Dexamethasone eye drops 4 times daily. Wit et al. [25] reported no graft displacement and postulated that sutureless and glue free graft resulted in even tension across the whole graft interface The mean operative time ± SD was 26.3±1.41 minutes (Range: 24-28 minutes), and the mean graft fixation time ± SD was 11.5±1.82 minutes (Range: 9-14 minutes).These durationsare comparable but longer than other studies Our results confirmed significantly lower postoperative signs and symptoms including irritation,pain, foreign body sensation, photophobia, hyperemia and chemosis at all follow up visits. None of our patients developed serious complications such as scleral necrosis, sclera thinning, graft necrosis, symblepharon, excessive bleeding, medial rectus muscle injury, or globe perforation.
CONCLUSION
Sutureless and glueless conjunctival limbal autograft following primary pterygiumexcision is safe,easy,effective and economic technique in primary pterygium surgery. 
